It is time for a move higher in biotech, says Mizuho's Jared Holz

Healthcare strategist Jared Holes joins us here on set for more. A breakout in the offing in biotech. Are you serious.Because you've been so negative for so long and so have investors. It's been admittedly a a super tough sector to call really either way, right. Because you've got hundreds of publicly traded stocks that in aggregate really don't sum up to anything, right.You got a lot of negatives, a lot of positives. I think for that reason it's been tough to make a broader industry call. But I just feel l ...